d ‐Alanine Hydrochloride and d ‐Alanine Dipeptide Have Biological Activity and Promote Human Proximal Tubular Epithelial Cell Viability
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202501108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Keisuke Sako und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Alanine, Dipeptides, Epithelial Cells, Kidney Tubules, Proximal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: JSPS, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Acute kidney injury (AKI) remains a significant clinical challenge with limited therapeutic options. While d ‐alanine shows promise in AKI treatment, its formulation requires l ‐alanine co‐inclusion for pharmaceutical stabilization through racemization. This study investigated the biological activity of synthetic d ‐alanine compounds in the human proximal tubular epithelial cell line (HK‐2). We synthesized d ‐alanine hydrochloride, a dipeptide, and a tripeptide and evaluated their effects on cell viability under normal and hypoxic conditions. d ‐Alanine hydrochloride (10 µM) and dipeptide (10 µM) significantly enhanced cell viability compared with the controls, with d ‐alanine hydrochloride demonstrating superior efficacy under hypoxic conditions. Gene expression analysis revealed that these compounds promoted cell cycle progression and increased cyclin B1 expression under hypoxic conditions. Notably, these synthetic forms maintained therapeutic efficacy without requiring l ‐alanine co‐inclusion. Although limited to in vitro experiments, our findings suggest that d ‐alanine hydrochloride and dipeptide forms are promising therapeutic candidates for AKI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Rheumatology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
- School of Pharmacy, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
- KAGAMI Inc., Ibaraki, Japan.
- Eshelman School of Pharmacy, The University of North Carolina At Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Keisuke Sako, Yasunori Iwata
Förderung
- JSPS
- Japan Society for the Promotion of Science
Zitieren
APA
Sako, K., Saito, Y., Nakade, Y., Linh, H. T., Koshino, A., Horikoshi, K., Yuasa, T., Tamai, A., Tsuge, S., Minami, T., Oshima, M., Nishioka, R., Ito, K., Mizushima, I., Hara, A., Sakai, N., Shimizu, M., Mita, M., Wada, T., …, & Iwata, Y. (2026). d ‐Alanine Hydrochloride and d ‐Alanine Dipeptide Have Biological Activity and Promote Human Proximal Tubular Epithelial Cell Viability. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501108
Vancouver
Sako K, Saito Y, Nakade Y, Linh HT, Koshino A, Horikoshi K, et al. d ‐Alanine Hydrochloride and d ‐Alanine Dipeptide Have Biological Activity and Promote Human Proximal Tubular Epithelial Cell Viability. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202501108
BibTeX
@article{Sako2026,
author = {Sako, Keisuke and Saito, Yohei and Nakade, Yusuke and Linh, Hoang Thuy and Koshino, Akihiko and Horikoshi, Keisuke and Yuasa, Takahiro and Tamai, Akira and Tsuge, Shunsuke and Minami, Taichiro and Oshima, Megumi and Nishioka, Ryo and Ito, Kiyoaki and Mizushima, Ichiro and Hara, Akinori and Sakai, Norihiko and Shimizu, Miho and Mita, Masashi and Wada, Takashi and Nakagawa-Goto, Kyoko and Iwata, Yasunori},
title = {d ‐Alanine Hydrochloride and d ‐Alanine Dipeptide Have Biological Activity and Promote Human Proximal Tubular Epithelial Cell Viability},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202501108}
}
EUVIMED